Design, synthesis and characterization of novel 2-(2,4-disubstituted-thiazole-5-yl)-3-aryl-3H-quinazoline-4-one derivatives as inhibitors of NF-kappaB and AP-1 mediated transcription activation and as potential anti-inflammatory agents.

Source:http://linkedlifedata.com/resource/pubmed/id/19064304

Download in:

View as

General Info

PMID
19064304